Leo Pharma poaches Novo Nordisk VP to lead US division

Leo Pharma has announced that Brian Hilberdink, senior vice president of sales at Novo Nordisk, will become president of Leo Pharma’s US division effective from March 14.

Brian Hilberdink | Photo: Brian Hilberdink

On Thursday, Leo Pharma has announced the appointment of a new EVP and president in the US, Brian Hilberdink, in a company press release.

Hilberdink is currently employed as senior vice president of sales at Novo Nordisk, and the job change will occur on March 14.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs